Steven Paul
2020
In 2020, Steven Paul earned a total compensation of $8.9M as Chief Executive Officer, President and Chairman at Karuna Therapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $287,500 |
|---|---|
| Option Awards | $8,031,191 |
| Salary | $575,000 |
| Other | $8,550 |
| Total | $8,902,241 |
Paul received $8M in option awards, accounting for 90% of the total pay in 2020.
Paul also received $287.5K in non-equity incentive plan, $575K in salary and $8.6K in other compensation.
Rankings
In 2020, Steven Paul's compensation ranked 1,007th out of 13,090 executives tracked by ExecPay. In other words, Paul earned more than 92.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,007 out of 13,090 | 92nd |
Division Manufacturing | 354 out of 5,624 | 94th |
Major group Chemicals And Allied Products | 123 out of 2,257 | 95th |
Industry group Drugs | 108 out of 1,957 | 95th |
Industry Pharmaceutical Preparations | 78 out of 1,462 | 95th |
Source: SEC filing on April 27, 2021.
Paul's colleagues
We found three more compensation records of executives who worked with Steven Paul at Karuna Therapeutics in 2020.